These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22891307)

  • 21. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
    Zhang Y; Jonkman L; Klauser A; Barkhof F; Yong VW; Metz LM; Geurts JJ
    Mult Scler; 2016 Oct; 22(12):1569-1577. PubMed ID: 26754802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal myelin content measures of slowly expanding lesions using 7T MRI in multiple sclerosis.
    Huerta MM; Conway DS; Planchon SM; Thoomukuntla B; Se-Hong O; Sakaie KE; Ontaneda D; Nakamura K
    J Neuroimaging; 2024; 34(4):451-458. PubMed ID: 38778455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology.
    Petzold A; Gveric D; Groves M; Schmierer K; Grant D; Chapman M; Keir G; Cuzner L; Thompson EJ
    Exp Neurol; 2008 Oct; 213(2):326-35. PubMed ID: 18619438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusivity in multiple sclerosis lesions: At the cutting edge?
    Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
    Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes.
    Wiggermann V; Hametner S; Hernández-Torres E; Kames C; Endmayr V; Kasprian G; Höftberger R; Li DKB; Traboulsee A; Rauscher A
    NMR Biomed; 2017 Aug; 30(8):. PubMed ID: 28470768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.
    van Walderveen MA; Kamphorst W; Scheltens P; van Waesberghe JH; Ravid R; Valk J; Polman CH; Barkhof F
    Neurology; 1998 May; 50(5):1282-8. PubMed ID: 9595975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.
    Sati P; Cross AH; Luo J; Hildebolt CF; Yablonskiy DA
    Neuroimage; 2010 Jul; 51(3):1089-97. PubMed ID: 20338247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.
    Barkhof F; Bruck W; De Groot CJ; Bergers E; Hulshof S; Geurts J; Polman CH; van der Valk P
    Arch Neurol; 2003 Aug; 60(8):1073-81. PubMed ID: 12925362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical mechanisms of phase contrast in gradient echo MRI.
    He X; Yablonskiy DA
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13558-63. PubMed ID: 19628691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing tissue damage in multiple sclerosis: a biomarker approach.
    Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
    Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain.
    Moore GR; Leung E; MacKay AL; Vavasour IM; Whittall KP; Cover KS; Li DK; Hashimoto SA; Oger J; Sprinkle TJ; Paty DW
    Neurology; 2000 Nov; 55(10):1506-10. PubMed ID: 11094105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis.
    Schirmer L; Antel JP; Brück W; Stadelmann C
    Brain Pathol; 2011 Jul; 21(4):428-40. PubMed ID: 21114565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.
    Mainero C; Benner T; Radding A; van der Kouwe A; Jensen R; Rosen BR; Kinkel RP
    Neurology; 2009 Sep; 73(12):941-8. PubMed ID: 19641168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.